MEGIN Masterclass

The 10 Common Evidence-Supported Indications for MEG in Epilepsy Surgery

Presented by Anto I. Bagić, MD, PhD, FAES, FACNS, Jeffrey R. Tenney, MD, PhD, FACNS, and Andrew J. Zillgitt, DO, FAES, FACNS.

Abstract: This Masterclass is a presentation of the article, [*Bagić AI, Funke ME, Kirsch HE, Tenney JR, Zillgitt AJ, Burgess RC. The 10 Common Evidence-Supported Indications for MEG in Epilepsy Surgery: An Illustrated Compendium. J Clin Neurophysiol. 2020 Nov;37(6):483-497.] supplemented with additional cases and literature review.

This webinar on The 10 Common Evidence-Supported Indications for MEG in Epilepsy Surgery* will be presented by Anto I. Bagić, MD, PhD, FAES, FACNS, Jeffrey R. Tenney, MD, PhD, FACNS, and Andrew J. Zillgitt, DO, FAES, FACNS.

Link to article: https://pubmed.ncbi.nlm.nih.gov/33165222/

Bios:

Anto I. Bagić, MD, PhD, FAES, FACNS

Professor, University of Pittsburgh Medical Center / University of Pittsburgh, Pittsburgh, PA

Jeffrey R. Tenney, MD, PhD, FACNS

Professor, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH

Andrew J. Zillgitt, DO, FAES, FACNS

Corewell Health William Beaumont University Hospital, Royal Oak, MI

 

About the American Clinical MEG Society (ACMEGS)

The paper on which this Masterclass is based was a project of the American Clinical MEG Society, published in the November 2020 issue of the Journal of Clinical Neurophysiology, which was a topical issue devoted to updates in Clinical Magnetoencephalography.

ACMEGS supports MEG centers in delivering quality comprehensive care to people with neurological disorders, by setting standards of care, advocating for access to high quality MEG center services, and providing education, knowledge, and other resources to its member centers.

ACMEGS does not endorse MEGIN or any other MEG vendor nor any specific product.

https://www.acmegs.org

*The MEGIN Masterclasses content and speakers selected are only for information purposes and MEGIN does not endorse any applications or treatments mentioned.

**TRIUX™ neo is intended to non-invasively record brain activity, and when interpreted by trained physicians, to help localize these active areas. All other applications are scientific research in nature. Please contact MEGIN for further information.